Title |
Albumin administration in the acutely ill: what is new and where next?
|
---|---|
Published in |
Critical Care, July 2014
|
DOI | 10.1186/cc13991 |
Pubmed ID | |
Authors |
Jean-Louis Vincent, James A Russell, Matthias Jacob, Greg Martin, Bertrand Guidet, Jan Wernerman, Ricard Ferrer Roca, Stuart A McCluskey, Luciano Gattinoni |
Abstract |
Albumin solutions have been used worldwide for the treatment of critically ill patients since they became commercially available in the 1940s. However, their use has become the subject of criticism and debate in more recent years. Importantly, all fluid solutions have potential benefits and drawbacks. Large multicenter randomized studies have provided valuable data regarding the safety of albumin solutions, and have begun to clarify which groups of patients are most likely to benefit from their use. However, many questions remain related to where exactly albumin fits within our fluid choices. Here, we briefly summarize some of the physiology and history of albumin use in intensive care before offering some evidence-based guidance for albumin use in critically ill patients. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 5 | 25% |
Spain | 5 | 25% |
Ecuador | 1 | 5% |
Canada | 1 | 5% |
Chile | 1 | 5% |
Italy | 1 | 5% |
Argentina | 1 | 5% |
Unknown | 5 | 25% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 8 | 40% |
Members of the public | 7 | 35% |
Science communicators (journalists, bloggers, editors) | 3 | 15% |
Scientists | 2 | 10% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Italy | 2 | <1% |
Colombia | 1 | <1% |
Ecuador | 1 | <1% |
Brazil | 1 | <1% |
Czechia | 1 | <1% |
Canada | 1 | <1% |
Egypt | 1 | <1% |
Mexico | 1 | <1% |
Romania | 1 | <1% |
Other | 0 | 0% |
Unknown | 309 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Postgraduate | 46 | 14% |
Student > Master | 35 | 11% |
Other | 28 | 9% |
Researcher | 27 | 8% |
Student > Bachelor | 25 | 8% |
Other | 83 | 26% |
Unknown | 75 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 186 | 58% |
Pharmacology, Toxicology and Pharmaceutical Science | 17 | 5% |
Biochemistry, Genetics and Molecular Biology | 10 | 3% |
Nursing and Health Professions | 7 | 2% |
Agricultural and Biological Sciences | 5 | 2% |
Other | 13 | 4% |
Unknown | 81 | 25% |